Pascal Hammel
Impact in
- Oncology top 1%
- Pancreatic and Hepatic Oncology Research
- PARP inhibition in cancer therapy
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 21
- Pancreatic and Hepatic Oncology Research 15
- PARP inhibition in cancer therapy 10
- Colorectal Cancer Treatments and Studies 2
-
- Cancer Genomics and Diagnostics 8
- Co-authors
- Eric Van Cutsem (16 shared papers)Teresa Macarulla (14 shared papers)Michele Reni (11 shared papers)Talia Golan (13 shared papers)Michael J. Hall (11 shared papers)Hedy L. Kindler (10 shared papers)Gershon Y. Locker (9 shared papers)Daniel Hochhauser (10 shared papers)
- Journals
- Journal of Clinical Oncology (14 papers)Cancers (1 paper)New England Journal of Medicine (1 paper)Therapeutic Advances in Medical Oncology (1 paper)Cancer Treatment Reviews (1 paper)
- Partner nations
- FranceUnited StatesSpain
In The Last Decade
Pascal Hammel
21 papers receiving 2.0k citations
Pascal Hammel's Hit Papers
Peers
Comparison fields: 5 of 63
- Oncology 1.8k
- Cancer Research 882
- Pulmonary and Respiratory Medicine 387
- Molecular Biology 687
- Pathology and Forensic Medicine 159
Countries citing papers authored by Pascal Hammel
This map shows the geographic impact of Pascal Hammel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Hammel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Hammel more than expected).
Fields of papers citing papers by Pascal Hammel
This network shows the impact of papers produced by Pascal Hammel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Hammel. The network helps show where Pascal Hammel may publish in the future.
Co-authors
The 25 scholars most cited alongside Pascal Hammel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Maintenance Olaparib for Germline BRCA -Mutated Metastatic Pancreatic Cancer Hit paper breakdown → | 2019 | 1468 |
| 2 | 2022 | 120 | |
| 3 | 2020 | 93 | |
| 4 | 2018 | 74 | |
| 5 | 2021 | 59 | |
| 6 | 2020 | 49 | |
| 7 | 2019 | 40 | |
| 8 | 2014 | 27 | |
| 9 | 2015 | 19 | |
| 10 | 2021 | 17 | |
| 11 | 2018 | 12 | |
| 12 | 2014 | 11 | |
| 13 | 2019 | 10 | |
| 14 | 2023 | 10 | |
| 15 | 2014 | 4 | |
| 16 | 2020 | 3 | |
| 17 | 2020 | 3 | |
| 18 | 2020 | 1 | |
| 19 | 2021 | 1 | |
| 20 | 2020 | 1 |
About Pascal Hammel
Pascal Hammel is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Genetics and Molecular Biology, having authored 21 papers that have together received 2.0k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (15 papers), PARP inhibition in cancer therapy (10 papers), Cancer Genomics and Diagnostics (8 papers), Advanced Breast Cancer Therapies (5 papers), BRCA gene mutations in cancer (4 papers), Economic and Financial Impacts of Cancer (3 papers), DNA Repair Mechanisms (3 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Oncology (1.8k citations), Cancer Research (882 citations), Pulmonary and Respiratory Medicine (387 citations), Molecular Biology (687 citations) and Pathology and Forensic Medicine (159 citations). Pascal Hammel has collaborated with scholars based in France, United States and Spain. Frequent co-authors include Eric Van Cutsem, Teresa Macarulla, Michele Reni, Talia Golan, Michael J. Hall, Hedy L. Kindler, Gershon Y. Locker, Daniel Hochhauser, Do‐Youn Oh and Dirk Arnold. Their work appears in journals such as Journal of Clinical Oncology, Cancers, New England Journal of Medicine, Therapeutic Advances in Medical Oncology and Cancer Treatment Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.